Viking Therapeutics, Inc.

NasdaqCM:VKTX Stock Report

Market Cap: US$4.7b

Viking Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:VKTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Jul 24SellUS$6,670,604Brian LianIndividual115,859US$58.78
30 Jul 24SellUS$1,029,912Marianne ManciniIndividual18,026US$57.82
30 Jul 24SellUS$922,212Gregory ZanteIndividual16,136US$58.71
04 Jan 24SellUS$268,500Gregory ZanteIndividual15,000US$17.90

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of VKTX?
Owner TypeNumber of SharesOwnership Percentage
State or Government45,9500.0412%
Individual Insiders2,315,1572.08%
Public Companies3,616,0773.24%
General Public22,366,16620.1%
Institutions83,093,03474.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.4%.


Top Shareholders

Top 25 shareholders own 57.25% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.9%
FMR LLC
16,619,430US$703.8m0.48%0.04%
9.12%
The Vanguard Group, Inc.
10,167,614US$430.6m0.7%0.01%
4.83%
BlackRock, Inc.
5,380,323US$227.9m-10.7%no data
4.19%
State Street Global Advisors, Inc.
4,674,067US$197.9m-8.75%0.01%
3.24%
Ligand Pharmaceuticals Incorporated
3,616,077US$153.1m0%no data
1.82%
JP Morgan Asset Management
2,032,024US$86.1m-4.23%0.01%
1.71%
Brian Lian
1,909,371US$80.9m2.06%no data
1.67%
Geode Capital Management, LLC
1,863,667US$78.9m0.25%0.01%
1.55%
Morgan Stanley, Investment Banking and Brokerage Investments
1,721,929US$72.9m111%0.01%
1.53%
Perceptive Advisors LLC
1,699,987US$72.0m136%1.68%
1.32%
Citadel Advisors LLC
1,472,676US$62.4m216%0.07%
1.22%
Pictet Asset Management Limited
1,361,510US$57.7m-1.44%0.05%
1.04%
Braidwell LP
1,156,977US$49.0m4.52%2.2%
1%
Susquehanna International Group, LLP, Asset Management Arm
1,115,105US$47.2m-20.6%0.08%
1%
J O Hambro Capital Management Limited
1,111,095US$47.1m54.9%0.41%
0.93%
AllianceBernstein L.P.
1,033,885US$43.8m-16.7%0.01%
0.83%
Westfield Capital Management Company, L.P.
930,370US$39.4m18.3%0.17%
0.78%
Invesco Ltd.
865,267US$36.6m24.2%0.01%
0.73%
Hood River Capital Management LLC
815,678US$34.5m14.2%0.52%
0.72%
UBS Asset Management AG
801,203US$33.9m-4.48%no data
0.66%
ClearBridge Investments, LLC
738,574US$31.3m26.3%0.02%
0.65%
Viking Global Investors LP
721,926US$30.6m-46.7%0.11%
0.64%
Charles Schwab Investment Management, Inc.
715,597US$30.3m6.57%no data
0.6%
Voya Investment Management LLC
674,139US$28.5m8.31%0.03%
0.53%
Principal Global Investors, LLC
593,734US$25.1m30%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 08:22
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Viking Therapeutics, Inc. is covered by 25 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew LuchiniBMO Capital Markets Equity Research
Mayank MamtaniB. Riley Securities, Inc.
Julian HarrisonBTIG